Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Evan Lederman

Orthopaedic Surgery Phoenix, AZ Medical Doctor

NPI 1932183456 CMS profile 86949

2222 E Highland Ave, Ste 300, Phoenix, AZ 85016

Open in the dashboard

General payments

$11,956,387

620 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,423,682 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Evan Lederman of Phoenix, AZ is reported in the CMS Open Payments database as having received $11,956,387 across 620 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,423,682 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,782,578 89
2024 General $2,325,618 82
2023 General $1,999,191 80
2022 General $1,661,390 110
2021 General $1,265,474 57
2020 General $989,591 88
2019 General $932,545 114

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Evan Lederman
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Evan Lederman were reported at $2,782,578. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Evan Lederman Orthopaedic Surgery median Middle half National median
2019 $932,545 $644 $140–$2,844 $163
2020 $989,591 $312 $75–$1,860 $114
2021 $1,265,474 $520 $117–$2,495 $132
2022 $1,661,390 $598 $128–$2,731 $149
2023 $1,999,191 $461 $128–$2,264 $160
2024 $2,325,618 $497 $134–$2,475 $164
2025 $2,782,578 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $11,946,636 537 payments
  2. Goode Surgical Inc $2,772 5 payments
  3. ImpactOrtho, Inc. $2,523 26 payments
  4. Stryker Corporation $902 11 payments
  5. Steelhead Surgical Inc $688 1 payment
  6. Shoulder Innovations, Inc. $592 2 payments
  7. FX Shoulder USA, Inc $376 3 payments
  8. Zimmer Biomet Holdings, Inc. $344 5 payments
  9. Smith+Nephew, Inc. $328 3 payments
  10. Embody, Inc. $286 3 payments
  11. Other $940 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $11,238,562 29 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $497,283 59 payments
  3. Consulting Fee $169,490 69 payments
  4. Travel and Lodging $33,808 120 payments
  5. Food and Beverage $13,451 340 payments
  6. Education $3,793 3 payments
Products named General payments · program years 2019–2025
  1. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System - MGS Glenospheres $5,300,986 8 payments
  2. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Revers $4,680,595 13 payments
  3. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System $4,680,535 12 payments
  4. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System $4,680,535 12 payments
  5. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System - MGS Baseplates $2,650,493 4 payments
  6. Arthrex Upper Extremity - Implants - Cerclage - Orthopedic - Knotted $2,650,493 4 payments
  7. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Revers - Cups $2,650,493 4 payments
  8. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Revers $2,459,549 7 payments
  9. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System $2,248,155 4 payments
  10. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Revers $2,248,155 4 payments
  11. Other $21,769,355 142 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$160,013

Of which drugs: $704

Medicare patients

363

Average age 73

Services billed

1,043

159 women, 204 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Ischemic heart disease 25%
Chronic kidney disease 19%
Depression 19%
Diabetes 18%
Atrial fibrillation 16%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 19 160 $115

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

620 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record